For more complex cases involving significant bony deformities or instability, open surgical procedures such as periacetabular osteotomy (PAO) or femoral osteotomy may be indicated to realign the hip joint and restore its biomechanical function. PAO, commonly used in patients with DDH, involves carefully repositioning the acetabulum to provide better coverage of the femoral head, thereby reducing contact pressures and improving joint stability. This procedure requires a high level of surgical expertise and is typically performed in specialized centers with experience in hip preservation surgery. Although the recovery period is longer compared to arthroscopy, PAO has shown excellent long-term outcomes in preventing or delaying the onset of osteoarthritis in appropriately selected patients. Similarly, femoral osteotomy may be performed to correct abnormal femoral head-neck anatomy in cases of FAI or to address malalignment issues contributing to joint overload. These osteotomies involve cutting and realigning the femur to optimize joint congruency and load distribution, ultimately preserving the patient’s natural hip for as long as possible.
Beyond surgical interventions, regenerative medicine and biologic therapies are gaining traction as promising adjuncts in hip preservation. Platelet-rich plasma (PRP) injections, stem cell therapies, and hyaluronic acid injections are being explored for their potential to hip preservation tissue healing, reduce inflammation, and slow the progression of early osteoarthritis. PRP, derived from the patient’s own blood, contains growth factors that may enhance the repair of damaged cartilage and labral tissues. While research on these therapies is still evolving, preliminary studies suggest they may provide symptomatic relief and improve joint function in select patients, particularly when combined with other conservative or surgical treatments. Additionally, advancements in cartilage restoration techniques, such as autologous chondrocyte implantation (ACI) and matrix-assisted chondrocyte transplantation (MACT), offer hope for repairing focal cartilage defects before they lead to widespread joint degeneration. These biologic approaches align with the overarching goal of hip preservation: to maintain the native joint’s structure and function while minimizing the need for prosthetic replacements.
The future of hip preservation lies in continued innovation, personalized treatment strategies, and a deeper understanding of the genetic and biomechanical factors contributing to hip pathology. Emerging technologies such as 3D imaging and patient-specific modeling allow for more precise preoperative planning and customized surgical interventions tailored to each individual’s unique anatomy. Artificial intelligence (AI) and machine learning algorithms are being developed to predict disease progression, optimize rehabilitation protocols, and identify patients who would benefit most from early intervention. Furthermore, collaborative efforts among orthopedic surgeons, radiologists, physical therapists, and researchers are essential for advancing the field and establishing evidence-based guidelines for hip preservation. Public awareness and education about the importance of early hip pain evaluation are also critical, as many individuals dismiss early symptoms, leading to delayed diagnosis and missed opportunities for joint-preserving treatments.
In conclusion, hip preservation represents a proactive and patient-centered approach to maintaining hip joint health, preventing degenerative changes, and optimizing quality of life. Through a combination of early diagnosis, conservative management, minimally invasive surgeries, and cutting-edge biologic therapies, healthcare providers can address a wide spectrum of hip disorders while preserving the native joint for as long as possible. As research and technology continue to advance, the field of hip preservation will undoubtedly expand, offering new hope for individuals seeking to maintain an active and pain-free lifestyle without the need for joint replacement. By prioritizing early intervention and adopting a multidisciplinary approach, the medical community can significantly reduce the burden of hip-related disabilities and improve long-term outcomes for patients of all ages.